The European Data Protection Board has launched a public consultation concerning anonymisation. The guidelines clarify the concept of anonymous data and provide a practical framework for determining whether data has been successfully anonymised. The framework can be...
On 3 June 2026, the Annex 2 of the ICH E6 (R3) guideline on Good Clinical Practice (GCP) was adopted. This marked the end of the second stage in the adoption process for the guideline, which began in January with the publication of the Principles and Annex 1. The aim...
The first National Summit on Rare Disease Policies took place in Rome on 15-16 June 2026, promoted by Italy's Ministry of Health on the initiative of Undersecretary Marcello Gemmato. The event brought together public institutions, and the scientific and medical...
The World Health Organization (WHO) has released a new discussion paper, Artificial intelligence and evidence-informed policy: emerging challenges and opportunities, examining how AI is starting to reshape the way health policies are designed, implemented and...
Fondazione per la Ricerca Farmacologica Gianni Benzi ETS, as partner of the European Rare Diseases Research Alliance (ERDERA), is co-organising the new ERDERA Ethics & Regulatory Webinar Series with the ERDERA training Work Stream . The series will examine ethical...
On 26 June, the United Nations International Day Against Drug Abuse and Illicit Trafficking is observed to raise public awareness about the risks associated with substance use and the importance of prevention, education, and access to treatment. On this occasion,...
Every year on 19 June, World Sickle Cell Disease Day is observed, providing an important opportunity to shine a spotlight on one of the most common inherited haemoglobinopathies worldwide and to promote greater awareness of a condition that is still often poorly...
The European Commission has opened a feedback period on the forthcoming European Biotech Act, allowing all stakeholders to express their views in the legislative debate. The European Biotech Act Ion establishing a framework of measures for strengthening Union’s...
The first phase of the DANTE (Digital Solutions for a Healthy, Active and Smart Life) project has been successfully completed, delivering significant results. The initiative was designed to support the digital transformation of businesses and public administrations in...
The European Medicines Agency (EMA) has launched a new pilot programme aimed at supporting the development of highly innovative medical devices with the potential to address unmet medical needs. “Breakthrough designation” may be granted to medical devices...
Recent posts in News